The USFDA further highlighted deficiencies in environmental monitoring in manufacturing areas, indicating gaps in ensuring controlled production conditions.

Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), is pleased to announce that it is receiving advisory services and funding from the National Research Council of Canada Industrial Research ...

The United States Food and Drug Administration (USFDA) has raised multiple concerns regarding manufacturing practices, documentation standards and contamination risks at Aurobindo ...

At 11:01 am on Wednesday, shares of Aurobindo Pharma declined 4.44 per cent to Rs 1132, down from its previous close of Rs 1184.65 apiece on the BSE.

India, Feb. 18 -- The share of this company, which focuses on generic and speciality pharmaceuticals, including antibiotics, cardiovascular (CVS), central nervous system (CNS), antiretrovirals, ...

GOTHENBURG, Sweden, February 18, 2026 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), ("Isofol" or the "Company"), announced today that the company's year-end report for January - December 202 ...

New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT ...

New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT FASPRO beyond lung ...

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

ICSE Class 10 English Language sample paper prepared by experts follows recent CISCE syllabus and marking scheme, offering ...